Overall Technical outlook

Price Summary

Suven Pharmaceuticals Limited's stock opened at 1092.2 on 2025-05-28, surged to 1119.0, hit a low of 1087.1, and closed up 1.52% at 1108.8, with 130132 shares traded.
Over the past 52 weeks, the stock reached a maximum price of 1334.2 and a minimum price of 610.5.
6 analysts forecast that the price of SUVENPHAR will range from 1290.0 to 1500.0, with an average expected price near 1396.6666.

Technicals

Support and Resistance: The current price is 1108.8, with support at 1050.1 and resistance at 1130.1. This range suggests that the price might move between these levels, with 1050.1 offering support and 1130.1 capping further gains for Suven Pharmaceuticals Limited.
SUVENPHAR supportResistance 0b33b1
Support/Resistance for SUVENPHAR


Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
SUVENPHAR aroon 0b33b1
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
SUVENPHAR bbands 0b33b1
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR for SUVENPHAR has recently shifted from a bearish to a bullish direction, indicating a potential trend reversal. When combined with other indicators, this change could signal a strong bullish trend, provided it is supported by a broader market trend. Investors should consider this a positive development, especially if other indicators align with this shift.
SUVENPHAR psar 0b33b1
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR stoch 0b33b1
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral for SUVENPHAR, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
SUVENPHAR trippleSMA 0b33b1
Tripple SMA chart for Suven Pharmaceuticals Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.